GeneLink, Inc. (GNLKQ)

GeneLink Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2012	FY 2011	FY 2010	FY 2009	FY 2008
Period Ending	Feb 11, 2026	Dec 31, 2012	Dec 31, 2011	Dec 31, 2010	Dec 31, 2009	Dec 31, 2008
Market Capitalization	0	3	12	6	13	13
Market Cap Growth	-86.67%	-79.22%	114.91%	-56.86%	3.41%	126.55%
Enterprise Value	-	3	13	7	14	12
Last Close Price	0.00	0.01	0.06	0.04	0.12	0.14
PS Ratio	0.01	1.20	2.63	0.73	1.55	2.01
PB Ratio	0.00	-0.96	-8.32	-7.26	-17.96	245.91
EV/Sales Ratio	-	1.24	2.75	0.83	1.61	1.93
Debt / Equity Ratio	-0.37	-0.41	-0.79	-1.08	-1.28	1.50
Net Debt / Equity Ratio	-0.33	-0.35	-0.29	-0.53	-1.01	-6.83
Net Debt / EBITDA Ratio	-0.50	-0.29	-0.12	-0.19	-0.30	0.16
Net Debt / FCF Ratio	-0.94	-0.35	-0.15	-0.29	-0.28	0.21
Asset Turnover	0.79	1.01	2.08	4.35	3.87	3.25
Inventory Turnover	3.33	3.50	4.42	7.97	5.92	4.88
Quick Ratio	0.12	0.13	0.43	0.44	0.38	0.46
Current Ratio	0.34	0.42	0.81	0.63	0.75	0.78
Return on Equity (ROE)	-	-	-	-	-	-2120.03%
Return on Assets (ROA)	-69.12%	-97.34%	-99.05%	-83.38%	-73.09%	-73.82%
Return on Capital Employed (ROCE)	229.80%	858.10%	-736.90%	-3906.40%	-1684.70%	-4441.60%
Earnings Yield	-21009.88%	-119.26%	-31.10%	-45.97%	-20.45%	-20.27%
FCF Yield	-10715.00%	-102.61%	-23.89%	-25.29%	-20.10%	-13.20%
Buyback Yield / Dilution	-25.57%	-18.76%	-33.95%	-20.54%	-35.51%	-71.52%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.